Abano Healthcare Group is listed on the New Zealand Stock Exchange. The Board of Abano is responsible for the corporate governance of the Company. The Board does this in line with internationally accepted best practice, and the Company’s corporate governance policies fully comply with the NZX Corporate Governance Best Practice Code.
Recent court cases have highlighted the high standard of oversight and responsibility required by directors. In addition, the proposed revamp of the Securities Act has stimulated discussion around director responsibilities and the heightened level of director risk and liability. It is important to ensure that overly onerous responsibilities do not build a barrier to obtaining and retaining a high calibre of directors. In addition, directors must be appropriately compensated for the level of due diligence, non-delegable tasks and risk involved in carrying out their duties.
We believe in diversity within our businesses, and recognise the value in different viewpoints and perspectives offered by people of different ages, race and gender. We have a strong representation of female directors on our Board (two out of seven directors), as well as many female senior executives in our business teams.
To view the full 2012 Corporate Governance Statement, click here